New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 4, 2013
09:19 EDTALU, CUK, LCC, ING, CCL, CPWR, ARIAOn The Fly: Pre-market Movers
HIGHER: Alcatel-Lucent (ALU), up 9.4% following upgraded to Buy at Deutsche Bank... ING Group (ING), up 3.6% after upgrade at BNP Paribas... ARIAD (ARIA), up 6.5% after updating on R&D and commercial progress for a newly launched drug and one under development... Navidea Biopharmaceuticals (NAVB), up 7.8% after its Lymphoseek meets primary efficacy endpoint in trial... LOWER: Compuware (CPWR), down 2.1%, after warning its fourth quarter earnings and revenue are likely to sharply miss consensus estimates... US Airways (LCC), down 1.8% following downgrade to Neutral from Buy at Bank of America Merrill Lynch... Carnival (CCL), down 1.7% after its "Triumph" cruiseship reported to have broken loose from its dock in Alabama.
News For CPWR;LCC;ALU;CCL;CUK;ARIA;ING From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 26, 2015
17:29 EDTCCLCarnival up almost 1% after annoucing plans to add cruise ships to fleet
Subscribe for More Information
16:31 EDTCCLCarnival enters strategic partnership to add nine cruise ships to fleet
Carnival signed two strategic memorandums of agreement that will add a total of nine new cruise ships to the company's industry-leading fleet over a four-year period from 2019-2022. The shipbuilding agreements, which include options for additional ship builds in the coming years, are subject to several conditions, including satisfactory financing. Italian shipbuilder Fincantieri S.p.A and German shipbuilder Meyer Werft will each build new ships based on Carnival Corporation's next-generation ship designs, which will produce the most efficient ships in the company's history. The new ships are expected to serve established cruise markets in North America and Europe, as well as newer markets, including China. Each new ship will be specifically designed and developed for the brand and guests it will serve, and support the company's overall goal of exceeding guest expectations and further elevating every aspect of the guest experience. Fincantieri, the world's largest cruise ship building company, will develop and construct five ships at its shipyards in Monfalcone and Marghera, Italy.
15:28 EDTCCLCarnival (CCL) April 45 straddle priced for 5.8% movement into Q1
Subscribe for More Information
15:20 EDTCCLNotable companies reporting before tomorrow's open
Subscribe for More Information
07:25 EDTALUThe Economist to hold a forum
Subscribe for More Information
March 25, 2015
10:00 EDTINGOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AB InBev (BUD) downgraded to Reduce from Overweight at HSBC... BreitBurn Energy (BBEP) downgraded to Sell from Neutral at UBS... DiamondRock (DRH) downgraded to Reduce from Neutral at SunTrust... Ethan Allen (ETH) downgraded to Hold from Buy at Gabelli... Felcor Lodging (FCH) downgraded to Neutral from Buy at SunTrust... Finish Line (FINL) downgraded to Neutral from Buy at B. Riley... Hannover Re (HVRRY) downgraded to Sell from Hold at Deutsche Bank... Hersha Hospitality (HT) downgraded to Reduce from Neutral at SunTrust... Host Hotels (HST) downgraded to Reduce from Neutral at SunTrust... ING Groep (ING) downgraded to Neutral from Buy at Goldman... Informatica (INFA) downgraded to Neutral from Buy at Mizuho... Kofax (KFX) downgraded to Hold from Buy at Canaccord... LRR Energy (LRE) downgraded to Sell from Neutral at UBS... LaSalle Hotel (LHO) downgraded to Reduce from Neutral at SunTrust... Munich Re (MURGY) downgraded to Sell from Hold at Deutsche Bank... Orbital ATK (OA) downgraded to Market Perform from Outperform at Wells Fargo... PCTEL, Inc. (PCTI) downgraded to Neutral from Buy at B. Riley... Quest Diagnostics (DGX) downgraded to Hold from Buy at Deutsche Bank... SJW Corp. (SJW) downgraded to Neutral from Outperform at RW Baird... Selective Insurance (SIGI) downgraded to Neutral from Buy at BofA/Merrill... Sonus (SONS) downgraded to Hold from Buy at Wunderlich... Starwood (HOT) downgraded to Neutral from Buy at SunTrust... Synchrony Financial (SYF) downgraded to Neutral from Buy at BofA/Merrill... Tesla (TSLA) downgraded to Underperform from Outperform at CLSA... Twitter (TWTR) downgraded to Hold from Buy at Pivotal Research... ZAGG (ZAGG) downgraded to Market Perform from Outperform at Northland... iDreamSky (DSKY) downgraded to Neutral from Overweight at JPMorgan.
09:31 EDTCCL, CUKCarnival names Julia Brown Chief Procurement Officer
Carnival (CCL; CUK) named Julia Brown to the newly created role of Chief Procurement Officer overseeing strategic sourcing and supplier relationship management. Brown most recently served as CPO on the global management team at Mondelez (MDLZ).
09:29 EDTARIAARIAD reports dismissal of class action suit in federal district court
ARIAD Pharmaceuticals announced that the United States District Court for the District of Massachusetts dismissed the shareholder class action lawsuit filed in late 2013 against the company and certain of its officers, directors and underwriters in connection with the events leading up to the temporary suspension of the marketing and commercial distribution of Iclusig on October 31, 2013, and subsequent re-launch in January 2014 based on revised U.S. prescribing information and a risk evaluation and mitigation strategy. The suit alleged that certain of the company defendants made a series of false and misleading statements regarding the safety, efficacy and commercial prospects of Iclusig. The Court granted the company’s motion to dismiss the lawsuit, concluding that the plaintiffs failed to establish that any such statements violated the company’s disclosure obligations as asserted in the complaint. “We are pleased that for the second time in as many weeks, the Court has granted our motion to dismiss what we believed from the outset was another meritless lawsuit,” said Harvey J. Berger, M.D., chairman and CEO. “Our corporate values of integrity and mutual respect are always at the forefront as we continue to focus on executing our plan for sustained revenue growth and operational excellence, leading to anticipated profitability in 2018.”
March 24, 2015
16:50 EDTINGING Groep downgraded to Neutral from Buy at Goldman
Subscribe for More Information
09:22 EDTARIAOn The Fly: Pre-market Movers
Subscribe for More Information
07:37 EDTARIAARIAD announces approval of Iclusig in Israel
ARIAD Pharmaceuticals and Medison Pharma announced that the Israeli Ministry of Health has granted regulatory approval for Iclusig, ponatinib, in Israel for adult patients with: Chronic phase, accelerated phase, or blast phase chronic myeloid leukaemia who are resistant to dasatinib or nilotinib, who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate, or who have the T315I mutation Philadelphia chromosome-positive acute lymphoblastic leukaemia who are resistant to dasatinib, who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate, or who have the T315I mutation. ARIAD submitted its application for Iclusig to the Israeli Ministry of Health in June 2014. Commercial launch of Iclusig is expected to occur in Q2.
March 23, 2015
13:20 EDTCCLCarnival volatility flat into Q1 and outlook
Subscribe for More Information
10:00 EDTCCLOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:30 EDTCUK, CCLCarnival downgraded to Hold from Buy at Deutsche Bank
Subscribe for More Information
March 20, 2015
10:00 EDTCCLOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:20 EDTCCLCarnival initiated with a Neutral at Wedbush
Subscribe for More Information
March 19, 2015
17:26 EDTINGING Groep files automatic mixed securities shelf
Subscribe for More Information
March 18, 2015
10:21 EDTINGHigh option volume stocks:
Subscribe for More Information
March 16, 2015
14:08 EDTINGEU regulator says time for fine-tuning, Reuters says
The Basel Committee on Banking Supervision believes the necessary bank regulatory framework is in place though some additional work must be done to finalize leverage ratio and capital floor rules, Reuters reported yesterday, citing statements by secretary-general William Coen at a financial conference in Doha. Coen added, "We're now at the state where we can take a step back and look to see how [the regulations] fit together," cautioning that further analysis must be data-driven but admitting that both banks and regulatory bodies were feeling "regulation fatigue." Publicly traded companies in the space include Banco Santander (SAN), Barclays (BCS), Credit Suisse (CS), Deutsche Bank (DB), HSBC (HSBC), ING Groep (ING), Lloyds Banking (LYG), RBS (RBS) and UBS (UBS). Reference Link
March 13, 2015
13:27 EDTARIAARIAD drug granted orphan designation as GIST treatment
ARIAD Pharmaceuticals' Iclusig was granted FDA orphan status on February 12 as a treatment of gastrointestinal stromal tumors, or GIST, according to a post to the agency's site. Reference Link
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use